Verrucatsid, 1 piece, 2 g, solution for external use


Directions for use and doses

Externally. Apply exactly to the treated area with a special applicator or a small thin wooden stick, avoiding contact with adjacent areas and mucous membranes.

Small papillomas (up to 2 mm) and filiform warts: lubricate once.

Larger papillomas and small warts (2–3 mm): apply 3–4 times, taking breaks to allow the solution to dry.

Warts on the hands and soles: treat 7–10 times at intervals of 3–4 minutes.

Keratomas and dry calluses: treat 3-4 times with an interval of 3-4 minutes.

Before removing warts on the hands with a dense keratinized surface, plantar warts, keratomas and dry calluses, they are softened with keratolytic ointment (for example, salicylic), covering the lubricated area with compress paper or plastic film and, on top of them, with a gauze bandage. Possible sealing with adhesive tape. Then the bandage or plaster is removed, the skin is steamed in hot water with the addition of soap and soda for 10–15 minutes, and the horny layers are cut off with nail scissors or tongs. The drug is applied to dried skin several times at intervals of 3–4 minutes for drying.

If it is necessary to apply the drug repeatedly, in order to avoid burns to the surrounding skin, it is advisable to lubricate it with zinc paste. The paste is removed with a dry gauze swab after the last portion of the drug has dried.

Genital warts: removed in the treatment room (not recommended on your own), applying the drug to each element separately 1-2 times with an interval of 3-4 minutes.

Repeated treatment, if necessary, is carried out 6–8 days after the crust falls off. The procedure can be repeated 4–5 times.

Verrucacid (for warts and papillae) (flask 2g)

A country

Russia
The country of production may vary depending on the batch of goods. Please check with the operator for detailed information when confirming your order.

Compound

Phenol, meta-cresol, ethyl alcohol.

pharmachologic effect

It has a cauterizing effect and coagulates proteins.

Indications for use

Warts (common, filiform, plantar), papillomas, genital warts of the skin, dry calluses, keratomas.

Mode of application

Externally. Small papillomas (up to 2 mm) - once. Larger papillomas and small warts (2-3 mm) - apply 3-4 times, taking a break to allow the applied liquid to dry. Warts on the hands and soles are treated 7-10 times with an interval of 3-4 minutes. Keratomas and dry calluses - 3-4 times with an interval of 3-4 minutes. Genital warts: applied to each element separately 1-2 times with an interval of 3-4 minutes. If necessary, re-treatment is carried out 6-8 days after the crusts are rejected. 4-5 procedures are allowed.

Interaction

The components of the drug easily dissolve in the ointment base, and therefore, applying ointments to the area treated with the drug is not recommended.

Side effect

Swelling and hyperemia of the eyelid when using the drug in the eye area. Burn (in case of contact with healthy skin).

Contraindications

Pigmented nevi; arrangement of elements on the red border of the lips and mucous membranes; treatment of skin surface area more than 20 sq.cm; children's age (up to 7 years). With caution: pregnancy, lactation, childhood.

Overdose

No data.

special instructions

It is not recommended to remove genital warts yourself. During pregnancy and lactation, the use of the drug is possible in cases where the expected benefit to the mother outweighs the potential risk to the fetus or child. During lactation, it is not recommended to remove formations localized on the mammary glands and hands. Do not allow the drug to come into contact with mucous membranes (especially the eyes). It is unacceptable to bandage the areas treated with the drug, seal them with a plaster, lubricate them with ointments and remove crusts; Do not reapply the drug before the dates indicated above. It is not recommended to apply the drug to formations located in folds and places with profuse sweating to avoid burns to healthy skin on the contacting surface or as a result of the drug spreading over wet skin. It is not recommended to lubricate with ointments or wash with water on the first day after treatment. If a burn occurs, it is recommended to use anti-burn and wound-healing drugs. When used correctly, the drug does not leave scars. Particular caution is required when treating children.

Precautionary measures

Avoid contact with healthy skin and mucous membranes (especially eyes). In case of contact with eyes, rinse them immediately with plenty of water and consult an ophthalmologist.

Do not bandage, tape or lubricate the treated areas with ointment, remove crusts, or reapply the drug before the specified time. It is necessary to ensure that the treated area dries in the air, to prevent its contact with clothing made of synthetic fabric, and not to wash it on the first day.

It is not recommended to apply Verrucacid to formations located in skin folds (inguinal folds, anal area, interdigital spaces, etc.) and heavily sweating areas, in order to avoid burns to unaffected skin.

If it is necessary to apply the drug repeatedly, in order to avoid burns to the surrounding skin, it is advisable to lubricate it with zinc paste. The paste is removed with a dry gauze swab after the last portion of Verrukacid has dried.

If the drug accidentally comes into contact with healthy skin, it is necessary to immediately, carefully, without rubbing, remove it from the skin, and then treat the affected areas with 10–40% ethyl alcohol or alcohol-containing liquids (lotion, cologne) and wash thoroughly with warm water and soap.

If a burn occurs, it is recommended to use anti-burn and healing agents.

Particular care should be taken when using the drug in children.

Verrucatsid, 1 piece, 2 g, solution for external use

Pharmaceutical action.

It has a cauterizing effect and coagulates proteins.

Indications.

Warts (common, filiform, plantar), papillomas, genital warts of the skin, dry calluses, keratomas.

Contraindications.

Pigmented nevi; arrangement of elements on the red border of the lips and mucous membranes; treatment of skin surface area more than 20 cm2; children's age up to 7 years.

With caution:

pregnancy, lactation period, childhood.

Dosage regimen.
Externally,
using a special applicator or a small thin wooden stick, avoiding contact of the drug with adjacent healthy areas of skin and mucous membranes. Small papillomas (up to 2 mm) - once. Larger papillomas and small warts (2–3 mm) are smeared 3–4 times, taking a break to allow the applied liquid to dry. Before removing warts with a dense keratinized surface on the hands, plantar warts, keratitis, dry calluses, it is necessary to remove horny layers from their surface: apply a keratolytic ointment (including salicylic acid ointment 10% or others) under an occlusive dressing for several hours ( possible sealing with adhesive tape). After which the bandage or adhesive plaster is removed, the skin is steamed in hot water with the addition of sodium bicarbonate and soap for 10–15 minutes and the horny layers are removed (cut off with nail scissors or tongs). The drug is applied to dried skin several times a day, taking 3-4 minute breaks to allow the drug to dry. Warts on the hands and soles are treated 7–10 times with an interval of 3–4 minutes. Keratomas and dry calluses - 3-4 times with an interval of 3-4 minutes. Genital warts: apply to each element separately 1-2 times with an interval of 3-4 minutes. If necessary, re-treatment is carried out 6–8 days after the crusts are rejected. 4–5 procedures are allowed.

Side effects.

Swelling and hyperemia of the eyelid when using the drug in the eye area. Burn (in case of contact with healthy skin).

Interaction.

The components of the drug easily dissolve in the ointment base, and therefore, applying ointments to the area treated with the drug is not recommended.

Special instructions.

It is not recommended to remove genital warts yourself. Their treatment should be carried out on an outpatient basis, in a treatment room by a dermatovenerologist or urologist. During pregnancy and lactation, the use of the drug is possible in cases where the expected benefit to the mother outweighs the potential risk to the fetus or child. During lactation, it is not recommended to remove formations localized on the mammary glands and hands. Do not allow the drug to come into contact with mucous membranes (especially the eyes). In case of contact, immediately rinse eyes with plenty of water and consult an ophthalmologist. It is unacceptable to bandage the areas treated with the drug, seal them with a plaster, lubricate them with ointments and remove crusts; Do not reapply the drug before the dates indicated above. Clothing made from synthetic fabrics should not touch the treated area of ​​skin. It is not recommended to apply the drug to formations located in folds (inguinal, anal area, interdigital spaces, etc.) and places with profuse sweating in order to avoid burns to healthy skin of the contacting surface or as a result of the drug spreading over wet skin. The treated area of ​​skin should be allowed to air dry; It is not recommended to lubricate with ointments or wash with water on the first day after treatment. If the drug accidentally comes into contact with healthy skin, it is necessary to immediately, carefully, without rubbing, remove it from the surface of the skin, and then treat the skin area with ethanol (10–40%) or ethanol-containing liquids (lotion, cologne) and rinse thoroughly with warm water and soap. If a burn occurs, it is recommended to use anti-burn and wound-healing drugs. When used correctly, the drug does not leave scars. Particular caution is required when treating children.

Registration number:

P N001835/01.
Trade name:
Verrukacid®.
INN or group name:
phenol, metacresol.
Dosage form:
solution for external use.

Compound:

  • Active ingredients:
    phenol – 588 mg, 3-methylphenol (metacresol) – 392 mg.
  • Excipients:
    ethyl alcohol (ethanol) 95% - 10 mg, purified water up to 1 g.

Description:

mobile oily liquid from pinkish or light yellow to brown with the smell of phenol.
Pharmacotherapeutic group:
local necrotizing agent.
ATX code
(D11AF).

Pharmacological properties

It has a cauterizing effect and coagulates skin proteins.

Indications for use

Common, filiform and plantar warts, papillomas, genital warts of the skin, dry calluses, keratomas.

Contraindications

Increased individual sensitivity to the components of the drug. Pigmented nevi (moles), rashes located on the red border of the lips and mucous membranes. Do not apply the drug to the skin surface area of ​​more than 20 cm2. Children under 7 years old.

Pregnancy and lactation period

The use of the drug is possible in cases where the expected benefit to the mother outweighs the potential risk to the fetus or child. During lactation, it is not recommended to remove formations located on the mammary glands and hands.

Directions for use and dosage
Verrukacid® is intended for external use only.
The drug is applied accurately

onto the treated area with a special applicator or a small thin wooden stick, avoiding it coming into contact with adjacent healthy areas of skin and mucous membranes. For small papillomas (up to 2 mm in size) and filamentous warts, Verrukacid® is applied once. Larger papillomas and small warts (2-3 mm in size) are smeared with the drug 3-4 times, taking breaks to allow the applied liquid to dry.

Before removing warts with a dense keratinized surface on the hands, plantar warts, keratomas, and dry calluses with Verrucacid®, it is necessary to remove horny layers from their surface. To do this, apply a keratolytic ointment (for example, 10% salicylic or other) for several hours, covering the lubricated area with compress paper or plastic film, and then use a gauze bandage. Possible sealing with adhesive tape. After this, the bandage or adhesive plaster is removed, the skin is steamed in hot water with the addition of soap and soda for 10-15 minutes and the horny layers are removed (cut off with nail scissors or tongs). Verrukacid® is applied to dried skin several times, taking 3-4 minute breaks to allow the drug to dry.

Warts on the hands and soles are treated with Verrukacid® 7-10 times with an interval of 3-4 minutes.

It is enough to treat keratomas and dry calluses 3-4 times with an interval of 3-4 minutes.

If it is necessary to apply the drug repeatedly, in order to avoid burns to the surrounding skin, it is advisable to lubricate it with zinc paste. The paste is removed with a dry gauze swab after the last portion of Verrukacid® has dried.

It is not recommended to remove genital warts yourself; they are treated with Verrucacid® in the treatment room of the clinic by a dermatovenereologist or urologist. The drug Verrukacid® is applied to each element separately 1-2 times with an interval of 3-4 minutes.

Repeated treatment, if necessary, is carried out 6-8 days after the crust falls off. 4-5 procedures are allowed.

Side effects

Burn (in case of contact with healthy skin). If the drug accidentally comes into contact with healthy skin, it is necessary to immediately, carefully, without rubbing, remove it from the skin, and then treat the affected areas with 10-40% ethyl alcohol or alcohol-containing liquids (vodka, lotion, cologne) and wash thoroughly with warm water and soap. If a burn occurs, it is recommended to use anti-burn and healing agents.

Swelling and redness of the skin when applied to the eye area, which goes away on its own.

Allergic reactions.

Overdose

Not identified.

Interaction with other drugs

The components of the drug easily dissolve in the ointment base, and therefore it is not recommended to lubricate the skin area treated with Verrucacid® with any ointments.

special instructions

Do not allow the drug to come into contact with mucous membranes, especially the mucous membrane of the eyes. In case of contact, immediately rinse eyes with plenty of water and consult an ophthalmologist.

It is unacceptable to bandage the areas treated with the drug, seal them with a plaster, lubricate them with any ointments and remove the crust; Do not reapply the drug before the dates indicated above. Clothing made of synthetic fabrics should not touch the area of ​​skin treated with the drug.

It is not recommended to apply Verrucacid® to formations located in skin folds (inguinal folds, anal area, interdigital spaces, etc.) and heavily sweating areas in order to avoid burns to unaffected skin of the contacting surface or as a result of the drug spreading over wet skin.

The area of ​​skin treated with Verrucacid® must be air-dried; it must not be lubricated with any ointments or washed with water on the first day after treatment.

When used correctly, the drug does not leave scars.

Particular care and caution is required when treating children with the drug.

Release form

Solution for external use in dark glass bottles with and without applicator, 2 and 10 g.

Each bottle, along with instructions for medical use, is placed in a cardboard pack.

Additionally, each cardboard pack can include a plastic lid with an applicator.

Storage conditions

In a place protected from light at a temperature of 15 to 25 ° C.

Keep out of the reach of children.

Best before date

5 years. Do not use after expiration date.

Conditions for dispensing from pharmacies

Dispensed without a prescription.

Rating
( 2 ratings, average 4.5 out of 5 )
Did you like the article? Share with friends:
For any suggestions regarding the site: [email protected]
Для любых предложений по сайту: [email protected]